Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bruker Corp (BRKR)
NASDAQ:BRKR
Holding BRKR?
Track your performance easily
BRKR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$54.55 - $94.86
Previous Close$60.49
Volume1.08M
Average Volume (3M)1.17M
Market Cap
$9.16B
Enterprise Value$11.29B
Total Cash (Recent Filing)$169.70M
Total Debt (Recent Filing)$2.27B
Price to Earnings (P/E)28.4
Beta1.17
Next Earnings
Feb 18, 2025EPS Estimate
$0.73Last Dividend Ex-Date
Aug 30, 2024Dividend Yield0.34%
Share Statistics
EPS (TTM)2.08
Shares Outstanding151,394,441
10 Day Avg. Volume1,592,135
30 Day Avg. Volume1,169,925
Standard Deviation0.10
R-Squared0.39
Alpha-0.00499
Financial Highlights & Ratios
Price to Book (P/B)4.88
Price to Sales (P/S)2.94
Price to Cash Flow (P/CF)2081.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.62
Enterprise Value/Gross Profit7.46
Enterprise Value/Ebitda17.98
Forecast
1Y Price Target
$76.33Price Target Upside32.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
Bruker News
Bulls Say, Bears Say
Bulls Say
M&A IntegrationBRKR sees further margin/EPS upside as the company executes on its M&A integration initiatives.
Product PortfolioBRKR has one of the best new product portfolios, is executing well in a challenging environment and can cut costs in recently acquired targets to support EPS.
ValuationThe stock has valuation support with shares trading at approximately 21x forward P/E, which is considered favorable compared to other areas in tools.
Bears Say
Financial PerformanceBRKR missed expectations and cut numbers as pharma headwinds caught up after years of outperforming peer growth.
Market OutlookConcerns exist about the pace of improvement in instrument demand and long-lead times for BRKR's major instruments.
Revenue GuidanceRevenue guidance for the fiscal year was lowered by approximately $60 million due to factors like delayed recovery in China and weaker biopharma results.
---
Ownership Overview
27.07% Insiders
30.44% Mutual Funds
7.67% Other Institutional Investors
18.58% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BRKR FAQ
What was Bruker Corp’s price range in the past 12 months?
Bruker Corp lowest stock price was $54.55 and its highest was $94.86 in the past 12 months.
What is Bruker Corp’s market cap?
Currently, no data Available
When is Bruker Corp’s upcoming earnings report date?
Bruker Corp’s upcoming earnings report date is Feb 18, 2025 which is in 101 days.
How were Bruker Corp’s earnings last quarter?
Bruker Corp released its earnings results on Nov 05, 2024. The company reported $0.6 earnings per share for the quarter, missing the consensus estimate of $0.601 by -$0.001.
Is Bruker Corp overvalued?
According to Wall Street analysts Bruker Corp’s price is currently Undervalued.
Does Bruker Corp pay dividends?
Bruker Corp pays a Quarterly dividend of $0.05 which represents an annual dividend yield of 0.34%. See more information on Bruker Corp dividends here
What is Bruker Corp’s EPS estimate?
Bruker Corp’s EPS estimate is $0.73.
How many shares outstanding does Bruker Corp have?
Bruker Corp has 151,394,440 shares outstanding.
What happened to Bruker Corp’s price movement after its last earnings report?
Bruker Corp reported an EPS of $0.6 in its last earnings report, missing expectations of $0.601. Following the earnings report the stock price went up 3.353%.
Which hedge fund is a major shareholder of Bruker Corp?
Among the largest hedge funds holding Bruker Corp’s share is Gotham Asset Management LLC. It holds Bruker Corp’s shares valued at 3M.
---
Bruker Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$76.33 (32.22% Upside)
$76.33 (32.22% Upside)
Blogger Sentiment
Bullish
BRKR Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 486.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $295.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.3%
Last 30 Days ▲ 24.4%
Last 30 Days ▲ 24.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
4.12%
12-Months-Change
Fundamentals
Return on Equity
20.10%
Trailing 12-Months
Asset Growth
60.04%
Trailing 12-Months
Company Description
Bruker Corp
Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.
---
BRKR Company Deck
---
BRKR Earnings Call
Q3 2024
0:00 / 0:00
---
BRKR Stock 12 Month Forecast
Average Price Target
$76.33
▲(32.22% Upside)
Technical Analysis
Best Analysts Covering BRKR
1 Year
1 Year Success Rate
16/26 ratings generated profit
1 Year Average Return
+10.69%
assigned a buy rating 4 days ago
Copying Brandon Couillard's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +10.69% per trade.
---